About RadNet, Inc. 
RadNet, Inc.
Pharmaceuticals & Biotechnology
RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. As of December 31, 2016, the Company had in operation 257 MRI systems, 157 CT systems, 47 PET or combination PET/CT systems, 48 nuclear medicine systems, 479 X-ray systems, 279 mammography systems, 551 ultrasound systems and 104 fluoroscopy systems.
Company Coordinates 
Company Details
1510 Cotner Ave , LOS ANGELES CA : 90025-3303
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 90 Schemes (46.04%)
Foreign Institutions
Held by 127 Foreign Institutions (8.17%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Dr. Howard Berger
Chairman of the Board, President, Chief Executive Officer, Director
Ms. Ruth Wilson
Senior Vice President of Human Resources, Director
Dr. John Crues
Vice President, Medical Director, Director, Corporate Secretary
Mr. David Swartz
Lead Independent Director
Mr. Marvin Cadwell
Independent Director
Mr. Lawrence Levitt
Independent Director
Dr. Michael Sherman
Independent Director
Revenue and Profits:
Net Sales:
498 Million
(Quarterly Results - Jun 2025)
Net Profit:
23 Million
Pharmaceuticals & Biotechnology
USD 5,537 Million (Small Cap)
137.00
NA
0.00%
0.35
4.80%
5.94






